Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tom look at today’s dip in the chart for $ITRM and the recovery. FDA PDUFA date is July 25th. Can this busy through $3.00?
Bullish after hours trading
The crowd is loading up and in!!
They are getting ready to send this UP
Eat these shares up, pound the ask. July it’s going higher!!
$ITRM on the FDA calendar
https://www.fdatracker.com/fda-calendar/
This calendar tracks upcoming PDUFA drug approval dates and FDA advisory committee meetings.
SHAREHOLDER MEETING tomorrow. June 23.
“However, the Company has decided to adjourn the AGM to take place on June 23, 2021 at 3 p.m., Irish time (10. a.m., Eastern Time) at Block 2, Floor 3, Harcourt Centre, Harcourt Street, Dublin 2, Ireland, to allow more opportunity for shareholders to vote on proposals described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 27, 2021.”
Very sorry you went through that Gov. I hope you continue to improve. Welcome back. Good to see you posting.
Welcome back Gov.
Attack the ask, eat them up. Supply will dry up soon and this moves higher
“In January, the incoming Biden administration began designing a new program dedicated to antiviral pills.
Last week, the first results of this planning took place. The Department of Health and Human Services announced that it would buy 1.7 million doses of molnupiravir from Merck for $ 1.2 billion, provided the current trial leads to authorization by the Food and Drug Administration. According to David Kessler, chief scientific officer of the Biden administration’s Covid-19 response team, the government may seek similar agreements for two other antiviral drugs in clinical trials.
The hope ‘is that by the end of the autumn we can find an antiviral remedy that can help us close this chapter of the epidemic’, said dr. Kessler said in an interview.
One of the remedies the government is considering is AT-527, developed by Atea Pharmaceuticals. The compound is already safe and effective as a treatment for hepatitis C, and early studies have suggested that it may also work against Covid-19. Roche has partnered with Atea to test it in humans, and the companies are currently conducting a late-stage clinical trial.
The other drug on the government’s radar was created by Pfizer scientists, adapted from a molecule initially designed in the early 2000s as a potential drug for SARS. The drug has been on the shelf for years, but scientists decided last year to change its structure so that it could work against the protease of the new coronavirus. More than 200 Pfizer researchers have joined forces over the attempt at the molecule, formerly known as PF-07321332.
The medicine was designed to be taken intravenously, but the Pfizer researchers succeeded in changing the structure to act as a pill. When mouse the medicine was administered orally, it reached high enough levels in the body to block the coronavirus. Pfizer launched a clinical trial in March to study its safety in humans, and expects to go test to later stages next month”
https://nationworldnews.com/a-pill-to-treat-covid-19-the-us-is-betting-on-that/
I didn’t see Brilacidin references in this article. This is a serious money move by the government. Vaccines and now antivirals.
Volcano
The ASK is stacked.
Dr Menon terminated and Dr B gone.
Merck & Pfizer both working on different antivirals. Brilacidin needs to move along faster.
“ I assure you he's good for another decade barring that. “
How can you assure that? On what basis?
Exactly. Dr Menon was terminated so it won’t be him.
Is there a succession plan if Leo retires? He can’t go on forever.
8-k filed
Item 5.02.
Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 8, 2021, Dr. Shahzad Malik, a director of Iterum Therapeutics plc (the “Company”), notified the Company of his resignation from the board of directors (the “Board”) of the Company, effective immediately. Dr. Malik also served as a member of the Company’s compensation and nominating and governance committees. Dr. Malik’s resignation was not the result of any dispute or disagreement with the Company or the Company’s Board on any matter relating to the operations, policies or practices of the Company. The Company thanks Dr. Malik for his contributions as a member of its Board and of its compensation and nominating and governance committees. Following Dr. Malik’s resignation, the Board approved a decrease in the size of the Board from eight to seven directors and as a result, there is not currently a vacancy on the Board
Item 8.01 Other Events
The Company’s annual general meeting of shareholders (the “AGM”) is currently scheduled to take place on June 16, 2021. However, the Company has decided to adjourn the AGM to take place on June 23, 2021 at 3 p.m., Irish time (10. a.m., Eastern Time) at Block 2, Floor 3, Harcourt Centre, Harcourt Street, Dublin 2, Ireland, to allow more opportunity for shareholders to vote on proposals described in the Company’s definitive proxy statement filed with the Securities and
$2.50-$3.00+ target zones next
“$1.50’s will seem cheap when it clips $2.00”
Here we go!!!!!!!
It could crush through $5.00 in a blink of an eye if there was such a leak
More EYES every week. Hold on! We cross mid June this week…the clock is ticking
Market Cap $92,545,417
Shares Outstanding 426,673,198
https://www.otcmarkets.com/stock/IPIX/quote
When IPIX reaches 500 million shares outstanding get a bag of popcorn ready.
600 million is the current authorized limit as I recall.
426,673,198 Shares Outstanding
The ride will get better once this clears $2.00-2.10 range IMO
If a FDA leak of early approval happens watch out.
426,673,198 Shares Outstanding 93,654,767 Market Cap (as of today)
Source https://www.otcmarkets.com/stock/IPIX/quote
Today’s closing price $ 0.216
Thanks for sharing that
No argument for this post?
$4.93 down to .21 cents. What’s management’s explanation for this?
Year after year dilution.
Alfasimga partnership hasn’t seemed to push this to $1.00.
Who’s the next partner?
I hope this blasts off in August back to $4.00 !!! I am afraid that market cap is unrealistic though.
Why didn’t the trial have 1000+ participants?
“Results will be here in August or September or quietly released in the 10Q in November depending on results.”
This is getting spooky! Did it work yes or no?
Where is the INTERIM DATA??
I think you could be right about the trial.
When it hits $3 bucks do you hold for $5+ at approval?
“.. B for C will be shelved like the others (OM/ABSSSI/K/UP)”
Very likely and on to the next Phase 2.
Pains of being on the pink sheets.